Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tumorigenesis and the angiogenic switch.
Bergers G, Benjamin LE. Bergers G, et al. Nat Rev Cancer. 2003 Jun;3(6):401-10. doi: 10.1038/nrc1093. Nat Rev Cancer. 2003. PMID: 12778130 Review.
Stromal-Based Signatures for the Classification of Gastric Cancer.
Uhlik MT, Liu J, Falcon BL, Iyer S, Stewart J, Celikkaya H, O'Mahony M, Sevinsky C, Lowes C, Douglass L, Jeffries C, Bodenmiller D, Chintharlapalli S, Fischl A, Gerald D, Xue Q, Lee JY, Santamaria-Pang A, Al-Kofahi Y, Sui Y, Desai K, Doman T, Aggarwal A, Carter JH, Pytowski B, Jaminet SC, Ginty F, Nasir A, Nagy JA, Dvorak HF, Benjamin LE. Uhlik MT, et al. Among authors: benjamin le. Cancer Res. 2016 May 1;76(9):2573-86. doi: 10.1158/0008-5472.CAN-16-0022. Cancer Res. 2016. PMID: 27197264 Free article.
Inhibition of Tie-2 signaling induces endothelial cell apoptosis, decreases Akt signaling, and induces endothelial cell expression of the endogenous anti-angiogenic molecule, thrombospondin-1.
Niu Q, Perruzzi C, Voskas D, Lawler J, Dumont DJ, Benjamin LE. Niu Q, et al. Cancer Biol Ther. 2004 Apr;3(4):402-5. doi: 10.4161/cbt.3.4.735. Epub 2004 Apr 29. Cancer Biol Ther. 2004. PMID: 14739779
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Lüthi U, Barberis A, Benjamin LE, Mäkinen T, Nobes CD, Adams RH. Wang Y, et al. Nature. 2010 May 27;465(7297):483-6. doi: 10.1038/nature09002. Nature. 2010. PMID: 20445537
RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis.
Kazerounian S, Gerald D, Huang M, Chin YR, Udayakumar D, Zheng N, O'Donnell RK, Perruzzi C, Mangiante L, Pourat J, Phung TL, Bravo-Nuevo A, Shechter S, McNamara S, Duhadaway JB, Kocher ON, Brown LF, Toker A, Prendergast GC, Benjamin LE. Kazerounian S, et al. Cancer Res. 2013 Jan 1;73(1):50-61. doi: 10.1158/0008-5472.CAN-11-3055. Epub 2012 Nov 7. Cancer Res. 2013. PMID: 23135917 Free PMC article.
The controls of microvascular survival.
Benjamin LE. Benjamin LE. Cancer Metastasis Rev. 2000;19(1-2):75-81. doi: 10.1023/a:1026552415576. Cancer Metastasis Rev. 2000. PMID: 11191067 Review.
Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.
Phung TL, Ziv K, Dabydeen D, Eyiah-Mensah G, Riveros M, Perruzzi C, Sun J, Monahan-Earley RA, Shiojima I, Nagy JA, Lin MI, Walsh K, Dvorak AM, Briscoe DM, Neeman M, Sessa WC, Dvorak HF, Benjamin LE. Phung TL, et al. Cancer Cell. 2006 Aug;10(2):159-70. doi: 10.1016/j.ccr.2006.07.003. Cancer Cell. 2006. PMID: 16904613 Free PMC article.
B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression.
Nucera C, Porrello A, Antonello ZA, Mekel M, Nehs MA, Giordano TJ, Gerald D, Benjamin LE, Priolo C, Puxeddu E, Finn S, Jarzab B, Hodin RA, Pontecorvi A, Nose V, Lawler J, Parangi S. Nucera C, et al. Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10649-54. doi: 10.1073/pnas.1004934107. Epub 2010 May 24. Proc Natl Acad Sci U S A. 2010. PMID: 20498063 Free PMC article.
Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability.
Xue Q, Hopkins B, Perruzzi C, Udayakumar D, Sherris D, Benjamin LE. Xue Q, et al. Cancer Res. 2008 Nov 15;68(22):9551-7. doi: 10.1158/0008-5472.CAN-08-2058. Cancer Res. 2008. PMID: 19010932 Free PMC article.
78 results
Jump to page
Feedback